Analyst Ratings for Rexnord Corp. (RXN)

Updated: 2017-07-27

Rexnord Corp. (NYSE:RXN) was awarded an average rating of Overweight from investment analysts following the stock. About 30 days ago, RXN was issued an average rating of Overweight.

Of the 9 analysts covering the stock, 5 gave it a buy rating, 1 issued an overweight rating, 1 issued a hold rating, 1 issued an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Many analysts weighed in on price targets for RXN. The maximum price target given was 27, implying potential capital gains of 15.88 percent. The most pessimistic price target was 18, implying potential capital losses of -22.75 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates downwards for this quarter, by about -3.7 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -7.14 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -1.17 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -4.89 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 1 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 1 analysts made negative revisions to their fiscal year's estimates.

The growth rate of RXN's earnings is estimated by analysts to be 88.49 percent. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Wall Street investors typically prefer a PEG ratio to be smaller than 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of RXN is 0.41.

RXN has traded between a high of 25.00 and a low of 15.80 over the past year. Today's price is 47.47 percent above the 52-week low, and 6.8 percent below the high. RXN has a price/earnings ratio of 35.85. Investors typically compare the P/E ratio to a company's peers in the industry. The RXN value stock report compares RXN to some of its peers using value stock charts. The stock has a market capitalization of $2.48 billion. RXN will post this quarters earnings in days, on 0000-00-00.